Moomoo AIのまとめ
On February 28, 2024, 180 Life Sciences Corp. announced the appointment of Blair Jordan to its Board of Directors. Jordan, deemed independent according to Nasdaq Capital Market rules, will serve as a Class II director until the 2024 Annual Meeting of Stockholders. Concurrently, the Board set its membership at four and continues to seek qualified independent directors. Jordan brings extensive experience, including his current role as CEO of HighMont Advisors Inc. and senior advisor at Evans & Evans, Inc. His previous positions include CFO and interim CEO at Ascent Industries Corp., and he has served on multiple boards across various sectors. Jordan's appointment includes membership on several Board committees and he will receive an annual retainer fee, with half of his compensation deferred until the company raises $1 million. The company will enter into an indemnification agreement with Jordan, similar to those with other directors.
On February 28, 2024, 180 Life Sciences Corp. announced the appointment of Blair Jordan to its Board of Directors. Jordan, deemed independent according to Nasdaq Capital Market rules, will serve as a Class II director until the 2024 Annual Meeting of Stockholders. Concurrently, the Board set its membership at four and continues to seek qualified independent directors. Jordan brings extensive experience, including his current role as CEO of HighMont Advisors Inc. and senior advisor at Evans & Evans, Inc. His previous positions include CFO and interim CEO at Ascent Industries Corp., and he has served on multiple boards across various sectors. Jordan's appointment includes membership on several Board committees and he will receive an annual retainer fee, with half of his compensation deferred until the company raises $1 million. The company will enter into an indemnification agreement with Jordan, similar to those with other directors.
2024年2月28日、１８０・ライフ・サイエンシスは、ブレア・ジョーダンを取締役会に任命したことを発表しました。ナスダック資本市場の規則に従って独立性が認められたジョーダン氏は、2024年株主総会までクラスIIの取締役として務めます。同時に、取締役会は4人のメンバーで構成され、その他の有能な独立取締役を探し続けています。ジョーダン氏は、現在はHighMont Advisors社のCEOおよびEvans＆Evans, Inc.のシニアアドバイザーとしての経験を含め、豊富な経験を持ちます。以前にはAscent Industries Corp.のCFOおよび臨時CEOを務め、様々な業界で複数の取締役...すべて展開
2024年2月28日、１８０・ライフ・サイエンシスは、ブレア・ジョーダンを取締役会に任命したことを発表しました。ナスダック資本市場の規則に従って独立性が認められたジョーダン氏は、2024年株主総会までクラスIIの取締役として務めます。同時に、取締役会は4人のメンバーで構成され、その他の有能な独立取締役を探し続けています。ジョーダン氏は、現在はHighMont Advisors社のCEOおよびEvans＆Evans, Inc.のシニアアドバイザーとしての経験を含め、豊富な経験を持ちます。以前にはAscent Industries Corp.のCFOおよび臨時CEOを務め、様々な業界で複数の取締役を務めてきました。ジョーダン氏の任命は、数多くの取締役会委員会のメンバーに加え、年間報酬として一定額の手数料を受け取ることが含まれており、その報酬の半分は同社が1,000,000ドルを調達するまで支払われません。同社は、ジョーダン氏と、他の取締役と同様の免責契約を締結します。
役に立った
役に立たない
